Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Costabel

Showing results (101-110 of 200) with videos related to

Pageof 20
Sort By:
Respiratory Medicine|May 20, 2014
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosisShinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 4, 2022
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of ExcellenceRobert P Baughman, Jan C Grutters, Athol U Wells, et al.
Respiration; International Review of Thoracic Diseases|October 10, 2009
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseAi Cui, Olaf Anhenn, Dirk Theegarten, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
The European Respiratory Journal|November 2, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concernsMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
The European Respiratory Journal|April 23, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 25, 2003
[Current trends in pneumology 2002 -- Part 1]Claus Kroegel, Angelika Reissig, Rainer Bonnet, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 16, 2015
A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumoniaJunji Itai, Shinichiro Ohshimo, Yoshiko Kida, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 10, 2003
Idiopathic bronchiolitis mimicking diffuse panbronchiolitisVenerino Poletti, Marco Chilosi, Rocco Trisolini, et al.
Pneumologie (Stuttgart, Germany)|May 31, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Pageof 20

Showing results (101-110 of 200) with videos related to

Sort By:
Pageof 20
Respiratory Medicine|May 20, 2014
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosisShinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 4, 2022
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of ExcellenceRobert P Baughman, Jan C Grutters, Athol U Wells, et al.
Respiration; International Review of Thoracic Diseases|October 10, 2009
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseAi Cui, Olaf Anhenn, Dirk Theegarten, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
The European Respiratory Journal|November 2, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concernsMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
The European Respiratory Journal|April 23, 2016
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosisMichael Kreuter, Marlies S Wijsenbeek, Martina Vasakova, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 25, 2003
[Current trends in pneumology 2002 -- Part 1]Claus Kroegel, Angelika Reissig, Rainer Bonnet, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|January 16, 2015
A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumoniaJunji Itai, Shinichiro Ohshimo, Yoshiko Kida, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 10, 2003
Idiopathic bronchiolitis mimicking diffuse panbronchiolitisVenerino Poletti, Marco Chilosi, Rocco Trisolini, et al.
Pneumologie (Stuttgart, Germany)|May 31, 2017
[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017]Jürgen Behr, Andreas Günther, Francesco Bonella, et al.
Pageof 20